Llorenç Coll-Mulet

815 total citations
12 papers, 663 citations indexed

About

Llorenç Coll-Mulet is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Llorenç Coll-Mulet has authored 12 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Genetics and 4 papers in Oncology. Recurrent topics in Llorenç Coll-Mulet's work include Chronic Lymphocytic Leukemia Research (8 papers), Cell death mechanisms and regulation (3 papers) and Cancer-related Molecular Pathways (3 papers). Llorenç Coll-Mulet is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Cell death mechanisms and regulation (3 papers) and Cancer-related Molecular Pathways (3 papers). Llorenç Coll-Mulet collaborates with scholars based in Spain, Austria and Ireland. Llorenç Coll-Mulet's co-authors include Joan Gil, Ana M. Cosialls, Daniel Iglesias‐Serret, Mercè de Frías, Antonio F. Santidrián, Gabriel Pons, Montserrat Barragán, Esther Castaño, Clara Campàs and Alícia Domingo and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Llorenç Coll-Mulet

12 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Llorenç Coll-Mulet Spain 11 452 263 156 93 90 12 663
Mercè de Frías Spain 13 511 1.1× 237 0.9× 184 1.2× 82 0.9× 103 1.1× 17 734
Ana M. Cosialls Spain 18 601 1.3× 255 1.0× 178 1.1× 99 1.1× 129 1.4× 29 842
Cathy E. Nolan United States 6 384 0.8× 206 0.8× 113 0.7× 51 0.5× 68 0.8× 8 585
Sandrine Jayne United Kingdom 18 578 1.3× 142 0.5× 210 1.3× 65 0.7× 104 1.2× 37 876
Vladimir Cmiljanović Switzerland 6 614 1.4× 120 0.5× 119 0.8× 56 0.6× 101 1.1× 15 794
Gabriella Cirmena Italy 18 383 0.8× 188 0.7× 83 0.5× 229 2.5× 98 1.1× 41 813
Silvia L. Locatelli Italy 15 373 0.8× 146 0.6× 67 0.4× 101 1.1× 144 1.6× 42 616
Sagarika Ray United States 7 773 1.7× 198 0.8× 93 0.6× 109 1.2× 89 1.0× 7 982
Jacqueline Sayyah United States 9 368 0.8× 178 0.7× 67 0.4× 78 0.8× 43 0.5× 11 534
Elsie White United States 7 443 1.0× 187 0.7× 61 0.4× 153 1.6× 83 0.9× 7 613

Countries citing papers authored by Llorenç Coll-Mulet

Since Specialization
Citations

This map shows the geographic impact of Llorenç Coll-Mulet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Llorenç Coll-Mulet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Llorenç Coll-Mulet more than expected).

Fields of papers citing papers by Llorenç Coll-Mulet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Llorenç Coll-Mulet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Llorenç Coll-Mulet. The network helps show where Llorenç Coll-Mulet may publish in the future.

Co-authorship network of co-authors of Llorenç Coll-Mulet

This figure shows the co-authorship network connecting the top 25 collaborators of Llorenç Coll-Mulet. A scholar is included among the top collaborators of Llorenç Coll-Mulet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Llorenç Coll-Mulet. Llorenç Coll-Mulet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Cebola, Inês, Joaquín Custodio, Mar Muñoz, et al.. (2015). Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer. Clinical Epigenetics. 7(1). 74–74. 38 indexed citations
2.
Cosialls, Ana M., Antonio F. Santidrián, Llorenç Coll-Mulet, et al.. (2012). Epigenetic Profile in Chronic Lymphocytic Leukemia using Methylation-Specific Multiplex Ligation-Dependent Probe Amplification. Epigenomics. 4(5). 491–501. 7 indexed citations
3.
Coll-Mulet, Llorenç, Fina Martínez‐Soler, Esther Castaño, et al.. (2011). Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme. PLoS ONE. 6(4). e18588–e18588. 109 indexed citations
4.
Coll-Mulet, Llorenç, Camila Rubio‐Patiño, Daniel Iglesias‐Serret, et al.. (2011). Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells. Epigenetics. 6(10). 1228–1235. 22 indexed citations
5.
Santidrián, Antonio F., Diana M. González‐Gironès, Daniel Iglesias‐Serret, et al.. (2010). AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells. Blood. 116(16). 3023–3032. 90 indexed citations
6.
Ropero, Santiago, Esteban Ballestar, Mario F. Fraga, et al.. (2009). Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity. Oncogene. 28(11). 1477–1484. 21 indexed citations
7.
Coll-Mulet, Llorenç & Joan Gil. (2009). Genetic alterations in chronic lymphocytic leukaemia. Clinical & Translational Oncology. 11(4). 194–198. 12 indexed citations
8.
Iglesias‐Serret, Daniel, Maria Piqué, Montserrat Barragán, et al.. (2009). Aspirin induces apoptosis in human leukemia cells independently of NF-κB and MAPKs through alteration of the Mcl-1/Noxa balance. APOPTOSIS. 15(2). 219–229. 30 indexed citations
9.
Iglesias‐Serret, Daniel, Mercè de Frías, Antonio F. Santidrián, et al.. (2006). Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells. Leukemia. 21(2). 281–287. 43 indexed citations
10.
Campàs, Clara, Ana M. Cosialls, Montserrat Barragán, et al.. (2006). Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Experimental Hematology. 34(12). 1663–1669. 65 indexed citations
11.
Barragán, Montserrat, Mercè de Frías, Daniel Iglesias‐Serret, et al.. (2006). Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase Cβ. Journal of Leukocyte Biology. 80(6). 1473–1479. 45 indexed citations
12.
Coll-Mulet, Llorenç, Daniel Iglesias‐Serret, Antonio F. Santidrián, et al.. (2006). MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. Blood. 107(10). 4109–4114. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mercè de Frías Breakdown of academic impact, for papers by Ana M. Cosialls Breakdown of academic impact, for papers by Cathy E. Nolan Breakdown of academic impact, for papers by Sandrine Jayne Breakdown of academic impact, for papers by Vladimir Cmiljanović Breakdown of academic impact, for papers by Gabriella Cirmena Breakdown of academic impact, for papers by Silvia L. Locatelli Breakdown of academic impact, for papers by Sagarika Ray Breakdown of academic impact, for papers by Jacqueline Sayyah Breakdown of academic impact, for papers by Elsie White
Rankless by CCL
2026